Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis

Area of Science:

• Rheumatology
• Epidemiology
• Public Health

Background:

• Juvenile rheumatoid arthritis (JRA) is a chronic autoimmune disease affecting children.
• Understanding mortality patterns in JRA is crucial for improving patient outcomes.
• Previous studies have indicated varying mortality causes and rates in JRA cohorts.

Purpose of the Study:

• To analyze mortality rates and causes of death in Finnish patients diagnosed with JRA.
• To compare mortality data between two distinct time periods: 1969-1979 and 1980-1990.
• To identify trends in JRA-related mortality and contributing factors.

Main Methods:

• Utilized a nationwide register of individuals with rheumatoid arthritis and allied diseases to identify JRA cases and deaths up to age 24.
• Collected death cause information through autopsy for the majority of identified cases.
• Calculated standardized mortality ratios (SMRs) for the two study periods.

Main Results:

• Observed 24 deaths in 1969-1979 and 23 deaths in 1980-1990, with SMRs of 2.7 and 2.4, respectively.
• Secondary amyloidosis was a significant cause of death, decreasing from 10 cases in the earlier period to 4 in the later period.
• An increase in deaths attributed to violence was noted in the later study period.

Conclusions:

• The decline in amyloidosis-related deaths may be linked to the introduction of cytotoxic drug treatments for severe JRA in the early 1980s.
• The rise in deaths from violence highlights a potential area for public health intervention and further research.
• Long-term monitoring of JRA patient mortality remains essential to adapt treatment and support strategies.